Several other vaccine projects involve viral vectors, but no others use adeno-associated viruses. Hundreds of AAVs infect humans and other mammals. Researchers in gene therapy turned to them as a safer alternative after a patient died in a study in 1999 from a severe immune reaction to a different type of viral vector.

Source: New York Times May 05, 2020 01:52 UTC